Day: August 18, 2020

BUFFALO, Wyo., Aug. 18, 2020 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Crazy Woman Creek  Bancorp, Inc. (OTCPink:CRZY), please note in the second paragraph, “The transaction is expected to increase book value per share by approximately $4.15,” should be, “The transaction is expected to increase book value per share by approximately $1.57.” Complete corrected text follows:Crazy Woman Creek  Bancorp, Inc. (OTCPink:CRZY), the wholly owned subsidiary of Buffalo Federal Bank, today announced the completion of its private placement of $2.0 million of 5.0% fixed-to-floating rate subordinated notes due 2030 (the “Note”) to a Wyoming bank. The Note will initially bear a fixed interest rate of 5.0% per year for five years and then reset quarterly to the three-month SOFR rate, plus...

Concord, NC, Aug. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer Incorporated (OTC:HYDI) or “the Company” announced today, as the exclusive coatings supplier and manufacturing partner for N8 Medical’s CeraShield™ coated endotracheal tubes, that the CeraShield™ coating has in recent testing demonstrated the ability to inhibit and reduce the growth of COVID-19 virus on tube surfaces. The testing showed statistically significant reduction in the growth of COVID-19 virus on the tube surface in 60 minutes. Ordinary uncoated endotracheal tubes either allowed increased virus growth or had no inhibitory effect. A clinical study is being planned by N8 Medical’s team.Ronald Bracken, President and Chief Operating Officer of N8 Medical, said, “Recent COVID-19 research has shown that the virus is able to adhere to plastic surfaces...

New York, Aug. 18, 2020 (GLOBE NEWSWIRE) —

SÃO PAULO, Brazil, Aug. 18, 2020 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) today announced that it has changed the time of its second quarter 2020 earnings conference call and webcast. To minimize scheduling conflicts amongst our analyst community, the conference call will now be held at 8:00 am ET on Friday, August 21, 2020. The conference call was previously scheduled for 11:00 am ET. There is no change to the dial-in information. A press release with second quarter 2020 financial results will be issued after the market closes on Thursday, August 20, 2020.Investors are invited to access the call (ID: 2791186) by dialing +1 (833) 519-1336 or +1 (914) 800-3898 at 8:00 a.m. Eastern Time on August 21, 2020. An audio replay of the call will be available through August 28, 2020 by dialing (855) 859-2056 or +1 (404) 537-3406...

CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP).Financial Highlights for the three months ended June 30, 2020:For the three months ended June 30, 2020, revenues increased by 50.6% to $12.8 million from $8.51 million in the same period in 2019.Quarterly gross profits increased to $2.3 million from $0.46 million, an increase of 401%, for the three months ended June 30, 2019. Gross Profit margin in second quarter improved to 18.32% from 5.5% in the same period in 2019.Income from operations in the second quarter of 2020 increased by 337.27% to $0.99 million from $0.22 million for...

CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), a leading manufacturer of sorbent minerals, parent company to Amlan International, announces that the European Patent Office has issued Patent EP 2906238. The patent covers the unique formulation of two existing mineral-based natural feed additives, Varium® for poultry and NeoPrime® for swine, that are helping global animal protein producers thrive in an era of antibiotic-free production.This patent will be validated in Belgium, France, Germany, Great Britain, Hungary, Italy, Poland, Portugal, Spain and Turkey, bringing the total number of countries to 12 that have issued patent protection for the mineral-based formula. Earlier this year, the United States Patent and Trademark Office issued a patent for the formulations featured in Varium and NeoPrime....

MONTREAL, Aug. 18, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that it has signed a contract for approx. $3MM (the “Contract”)  with HPQ Nano Silicon Powders Inc (“HPQ NANO” or the “Client”), a wholly owned subsidiary of HPQ Silicon Resources Inc (“HPQ”).This Contract has been developed to exploit the benefits of the novel PUREVAP™ Nano Silicon Reactor (NSiR) to make nano Silicon powder with the battery market as a principle target. Specifically, this program has been divided into two phases; i) to...

TORRANCE, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle cell disease treatment, announced today the submission of an application to the Saudi Food and Drug Authority (SFDA) for Marketing Authorization (MA) for Endari® in the Kingdom of Saudi Arabia. This follows Emmaus’ announcement that the SFDA had granted Endari® a priority review designation as part of its program to expedite the review of drugs that are expected to have a significant impact on the treatment of a disease with unmet medical need. Endari®, Emmaus’ prescription grade L-glutamine oral powder, is approved by the United States FDA to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.Endari® can currently be prescribed in Saudi Arabia on a named patient...

Company Continues Trend of Profitability in 2020Portland, OR, Aug. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sortis Holdings, Inc. (OTC PINK: SOHI), a diversified investment firm, today announced results for the second quarter of 2020.  For the quarter ending June 30, 2020, Sortis Holdings reported total revenue of $1,232,656 and net income of $586,958 or around $0.04 earnings per share.Management CommentaryJef Baker, President and Chief Executive Officer, stated: “Sortis Holdings now has a stable, growing level of assets under management that provide a predictable and ongoing source of revenue. Since the sale of our Bank in 2017 and the subsequent building of our Company, we have back-to-back quarters of profitability, and our business continues to grow.  While the current impact of COVID-19 on our economy is devastating,...

Bintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf RegionUpfront development payment100% funding for commercial registration of Ii-Key- SARS-CoV-2 prophylactic vaccine against COVID-19 in MalaysiaLicensing fees upon approvalPotential $150 million in GNBT revenues for vaccine sales in MalaysiaMIRAMAR, Fla., Aug. 18, 2020 (GLOBE NEWSWIRE) — This press release corrects a prior version published on August 18, 2020. The corrected press release reads:Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today has signed a non-binding memorandum of understanding (MOU) with Bintai Kinden Corporation of Malaysia for the development and commercialization of the Ii-Key-SARS-CoV-2 coronavirus vaccine....